Literature DB >> 35902455

Role of papillary thyroid carcinoma patients with Hashimoto thyroiditis: evaluation of oxidative stress and inflammatory markers.

Natália Medeiros Dias Lopes1, Hannah Hamada Mendonça Lens1, Walison Augusto da Silva Brito1,2, Julya Karen Bianchi1, Poliana Camila Marinello1,3, Rubens Cecchini4, André Armani5, Alessandra Lourenço Cecchini6.   

Abstract

PURPOSE: Papillary thyroid carcinoma (PTC) is the most frequent subtype of thyroid cancer; Hashimoto's thyroiditis (HT), autoimmune disease, commonly affects the thyroid gland; there is possibly a correlation between both, but the exact mechanisms that involve this relationship are still under debate. Since oxidative stress (OS) and the inflammatory environment participate in the development of several types of cancer, the objective of the present study was to establish the microenvironment and systemic participation of OS and inflammatory markers in patients with PTC and HT.
METHODS: Blood and tissue samples were collected from 115 patients: BENIGN (n = 63); PTC (n = 27); HT (n = 15) and PTC + HT (n = 10), and sixty-three were samples from healthy individuals (control group).
RESULTS: Superoxide dismutase, Catalase, reduced Glutathione, markers of lipid peroxidation and inflammation were evaluated in blood. Immunohistochemistry was performed on 3-nitrotyrosine, 4-hydroxynonenal, Ki-67 and VEGF. The results indicate that antioxidant enzymes were more active in groups with thyroid disorders compared to control, while the concentration of Reduced glutathione was reduced in BENIGN and PTC groups. When PTC and PTC + HT groups were analyzed, no significant differences were found in relation to the antioxidant defense and inflammatory markers. The ability to contain the induced lipid peroxidation was lower and a high level of malondialdehyde was observed in the PTC group. All immunohistochemical markers had higher scores in the PTC group compared to PTC + HT.
CONCLUSION: There was a more pronounced presence of OS and a greater activity of cell proliferation and angiogenesis markers in PTC than in PTC + HT group.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  Hashimoto's thyroiditis; Inflammatory markers; Oxidative stress; Papillary thyroid carcinoma

Mesh:

Substances:

Year:  2022        PMID: 35902455     DOI: 10.1007/s12094-022-02891-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.340


  48 in total

1.  Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland.

Authors:  M E DAILEY; S LINDSAY; R SKAHEN
Journal:  AMA Arch Surg       Date:  1955-02

Review 2.  The Current Histologic Classification of Thyroid Cancer.

Authors:  Sylvia L Asa
Journal:  Endocrinol Metab Clin North Am       Date:  2019-03       Impact factor: 4.741

3.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

Review 4.  NADPH oxidases: new actors in thyroid cancer?

Authors:  Rabii Ameziane-El-Hassani; Martin Schlumberger; Corinne Dupuy
Journal:  Nat Rev Endocrinol       Date:  2016-05-13       Impact factor: 43.330

5.  Increased Incidental Thyroid Cancer in Patients With Subclinical Chronic Lymphocytic Thyroiditis.

Authors:  David Jackson; Rachel S Handelsman; Josefina C Farrá; John I Lew
Journal:  J Surg Res       Date:  2019-08-12       Impact factor: 2.192

Review 6.  Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy.

Authors:  Francesca Ragusa; Poupak Fallahi; Giusy Elia; Debora Gonnella; Sabrina Rosaria Paparo; Claudia Giusti; Leonid P Churilov; Silvia Martina Ferrari; Alessandro Antonelli
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2019-11-26       Impact factor: 4.690

7.  Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle.

Authors:  B Gonzalez Flecha; S Llesuy; A Boveris
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

Review 8.  Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease.

Authors:  Margaret P Rayman
Journal:  Proc Nutr Soc       Date:  2018-09-13       Impact factor: 6.297

9.  Hashimoto's thyroiditis attenuates progression of papillary thyroid carcinoma: deciphering immunological links.

Authors:  Oksana Sulaieva; Oleksii Selezniov; Dmytro Shapochka; Nataliia Belemets; Oleksandr Nechay; Yelizaveta Chereshneva; Dibakhan Tsomartova; Marina Ivanova
Journal:  Heliyon       Date:  2020-01-08

10.  Thyroid Carcinoma Coexisting with Hashimoto's Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis.

Authors:  Csaba Molnár; Sarolta Molnár; Judit Bedekovics; Attila Mokánszki; Ferenc Győry; Endre Nagy; Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2019-01-21       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.